Universal Ibogaine Inc. IBOGF
0.00 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.008 Day range 0.008
0.00001 52-week range 0.35
- YTD
- -96.97%
- 1 year
- -98.18%
Financial health
Altman Z-Score
-10.97 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.7×
FY 2017 5y median -3.1× FY 2022
P/S 6.8×
FY 2017 5y median 0.0× FY 2022
P/B 1.9×
FY 2017 5y median 4.0× FY 2022
P/FCF -1.7×
FY 2017 5y median -3.6× FY 2022
EV/EBITDA -1.8×
FY 2017 5y median 1.8× FY 2022
EV/Sales 7.8×
FY 2017 5y median 0.0× FY 2022
FCF Yield -60.4%
FY 2017 5y median -27.5% FY 2022
Profitability
Gross Margin 100.0%
FY 2017 5y median 0.0% FY 2022
Operating Margin 46.4%
FY 2017 5y median 0.0% FY 2022
Net Margin -980.2%
FY 2017 5y median 0.0% FY 2022
ROE -266.2%
FY 2017 5y median -131.4% FY 2022
ROIC 8.7%
FY 2017 5y median 0.4% FY 2022
ROA -166.1%
FY 2017 5y median -101.5% FY 2022
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2022
Operating Income 113.0%
FY 2017 FY 2022
EPS (diluted) -82.8%
FY 2017 FY 2022
Free Cash Flow -36.3%
FY 2017 FY 2022
Financial Health
Current Ratio 1.6×
FY 2017 5y median 5.3× FY 2022
Quick Ratio 1.6×
FY 2017 5y median 5.3× FY 2022
Debt / Equity 0.4×
FY 2017 5y median 0.0× FY 2022
Net Debt / EBITDA -0.2×
FY 2017 5y median -0.5× FY 2022
Interest Coverage 7.3×
FY 2017 5y median 0.0× FY 2022
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-07-31
